ANNEXON, INC. Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price
ANNEXON, INC. (ANNX) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price of $3.29 per share for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice · last filed 2026-08-12
- ANNEXON, INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2026-03-31 was $3.74, a 159.72% increase year-over-year.
- ANNEXON, INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2025-03-31 was $1.44, a 30.10% decline year-over-year.
- ANNEXON, INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2024-03-31 was $2.06, a 3.52% increase year-over-year.
- ANNEXON, INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2023-03-31 was $1.99, a 73.04% decline year-over-year.
- ANNEXON, INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2025 was $2.36, a 26.71% decline from fiscal 2024.
- ANNEXON, INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2024 was $3.22, a 70.37% increase from fiscal 2023.
- ANNEXON, INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2023 was $1.89, a 64.20% decline from fiscal 2022.
- ANNEXON, INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2022 was $5.28, a 28.47% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 12 month |
|---|---|---|---|---|
| 2026-06-30 | $3.29 10-Q · filed 2026-08-12 | |||
| 2026-03-31 | $3.74 10-Q · filed 2026-05-07 | |||
| 2025-12-31 | $2.36 10-K · filed 2026-03-30 | |||
| 2025-09-30 | $1.47 10-Q · filed 2025-11-10 | |||
| 2025-06-30 | $1.44 10-Q · filed 2025-08-14 | |||
| 2025-03-31 | $1.44 10-Q · filed 2025-05-12 | |||
| 2024-12-31 | $3.22 10-K · filed 2025-03-03 | |||
| 2024-09-30 | $3.69 10-Q · filed 2024-11-14 | |||
| 2024-06-30 | $2.74 10-Q · filed 2024-08-12 | |||
| 2024-03-31 | $2.06 10-Q · filed 2024-05-13 | |||
| 2023-12-31 | $1.89 10-K · filed 2024-03-26 | |||
| 2023-09-30 | $1.99 10-Q · filed 2023-11-13 | |||
| 2023-06-30 | $1.99 10-Q · filed 2023-08-07 | |||
| 2023-03-31 | $1.99 10-Q · filed 2023-05-08 | |||
| 2022-12-31 | $5.28 10-K · filed 2023-03-06 | |||
| 2022-09-30 | $5.65 10-Q · filed 2022-11-03 | |||
| 2022-06-30 | $7.38 10-Q · filed 2022-08-08 | |||
| 2022-03-31 | $7.38 10-Q · filed 2022-05-09 | |||
| 2021-12-31 | $4.11 10-K · filed 2022-03-01 | |||
| 2021-09-30 | $5.46 10-Q · filed 2021-11-09 | |||
| 2021-06-30 | $5.08 10-Q · filed 2021-08-16 | |||
| 2021-03-31 | $3.57 10-Q · filed 2021-05-17 | |||
| 2020-12-31 | $2.33 10-K · filed 2021-03-25 | |||
| 2020-09-30 | $2.33 10-Q · filed 2020-11-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |